[Comparative evaluation of thiphosphamide, cyclophosphane, methotrexate and 5-fluorouracil in the treatment of breast cancer].
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008593:Menopause; D008598:Menstruation; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use*
D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil; D008727:Methotrexate
Sravnitel'naia otsenka éffektivnosti tiofosfamida, tsiklofosfana, metotreksata i 5-ftoruratsila pri lechenii raka molochnoĭ zhelezy.